Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Sep;93(Suppl 1):7–11. doi: 10.1111/j.1365-2249.1993.tb06215.x

The clinical relevance of ANCA in vasculitis.

W L Gross 1, S Hauschild 1, N Mistry 1
PMCID: PMC1554937  PMID: 8365024

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosch X., Mirapeix E., Font J., Borrellas X., Rodríguez R., López-Soto A., Ingelmo M., Revert L. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991 Sep;36(3):107–113. [PubMed] [Google Scholar]
  2. Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol. 1992 Mar;37(3):124–130. [PubMed] [Google Scholar]
  3. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dolman K. M., Damsma I., Tool A. T., Sonnenberg A., von dem Borne A. E., Goldschmeding R. A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase. Clin Exp Immunol. 1993 Apr;92(1):58–64. doi: 10.1111/j.1365-2249.1993.tb05948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Duerr R. H., Targan S. R., Landers C. J., LaRusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1385–1391. [PubMed] [Google Scholar]
  6. Efthimiou J., Spickett G., Lane D., Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet. 1991 Apr 27;337(8748):1037–1038. doi: 10.1016/0140-6736(91)92694-w. [DOI] [PubMed] [Google Scholar]
  7. Fienberg R., Mark E. J., Goodman M., McCluskey R. T., Niles J. L. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol. 1993 Feb;24(2):160–168. doi: 10.1016/0046-8177(93)90295-r. [DOI] [PubMed] [Google Scholar]
  8. Gallicchio M. C., Savige J. A. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin Exp Immunol. 1991 May;84(2):232–237. doi: 10.1111/j.1365-2249.1991.tb08154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Geffriaud-Ricouard C., Noël L. H., Chauveau D., Houhou S., Grünfeld J. P., Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol. 1993 Mar;39(3):125–136. [PubMed] [Google Scholar]
  10. Gross W. L., Csernok E., Schmitt W. H. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects. Klin Wochenschr. 1991 Sep 3;69(13):558–566. doi: 10.1007/BF01649318. [DOI] [PubMed] [Google Scholar]
  11. Gross W. L., Hauschild S., Schmitt W. H. Immundiagnostische und immunopathogenetische Bedeutung von Anti-Neutrophilen-Zytoplasma-Antikörpern. Dtsch Med Wochenschr. 1993 Feb 12;118(6):191–199. doi: 10.1055/s-2008-1059318. [DOI] [PubMed] [Google Scholar]
  12. Gueirard P., Delpech A., Gilbert D., Godin M., Le Loet X., Tron F. Anti-myeloperoxidase antibodies: immunological characteristics and clinical associations. J Autoimmun. 1991 Jun;4(3):517–527. doi: 10.1016/0896-8411(91)90163-7. [DOI] [PubMed] [Google Scholar]
  13. Halbwachs-Mecarelli L., Nusbaum P., Noël L. H., Reumaux D., Erlinger S., Grünfeld J. P., Lesavre P. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1992 Oct;90(1):79–84. doi: 10.1111/j.1365-2249.1992.tb05835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498. doi: 10.7326/0003-4819-116-6-488. [DOI] [PubMed] [Google Scholar]
  15. Jennette J. C., Falk R. J. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 1990 Jun;15(6):517–529. doi: 10.1016/s0272-6386(12)80521-x. [DOI] [PubMed] [Google Scholar]
  16. Jennette J. C., Falk R. J. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis. 1991 Aug;18(2):184–187. doi: 10.1016/s0272-6386(12)80878-x. [DOI] [PubMed] [Google Scholar]
  17. Jennette J. C., Falk R. J. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheumatol. 1992 Feb;4(1):9–15. [PubMed] [Google Scholar]
  18. Juby A., Johnston C., Davis P., Russell A. S. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol. 1992 Mar;31(3):185–188. doi: 10.1093/rheumatology/31.3.185. [DOI] [PubMed] [Google Scholar]
  19. Kallenberg C. G., Mulder A. H., Tervaert J. W. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992 Dec;93(6):675–682. doi: 10.1016/0002-9343(92)90202-m. [DOI] [PubMed] [Google Scholar]
  20. Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 1993 Mar;36(3):365–371. doi: 10.1002/art.1780360312. [DOI] [PubMed] [Google Scholar]
  21. Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., Calabrese L. H., Fries J. F., Lie J. T., Lightfoot R. W., Jr The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990 Aug;33(8):1101–1107. doi: 10.1002/art.1780330807. [DOI] [PubMed] [Google Scholar]
  22. Lee S. S., Lawton J. W., Chan C. E., Li C. S., Kwan T. H., Chau K. F. Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol. 1992 Oct;31(10):669–673. doi: 10.1093/rheumatology/31.10.669. [DOI] [PubMed] [Google Scholar]
  23. Metzger D., Röther E., Melchers I., Lang B., Peter H. H. Anti-Neutrophilen-Zytoplasma-Antikörper (ANCA) bei rheumatoider Arthritis: Spezifität und klinische Relevanz? Immun Infekt. 1993 Apr;21 (Suppl 1):18–20. [PubMed] [Google Scholar]
  24. Nässberger L., Jonsson H., Sjöholm A. G., Sturfelt G., Heubner A. Circulating anti-elastase in systemic lupus erythematosus. Lancet. 1989 Mar 4;1(8636):509–509. doi: 10.1016/s0140-6736(89)91420-7. [DOI] [PubMed] [Google Scholar]
  25. Nässberger L., Ljungh A., Schumacher G., Kollberg B. beta-Glucuronidase antibodies in ulcerative colitis. Lancet. 1992 Sep 19;340(8821):734–735. doi: 10.1016/0140-6736(92)92279-o. [DOI] [PubMed] [Google Scholar]
  26. Nölle B., Specks U., Lüdemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989 Jul 1;111(1):28–40. doi: 10.7326/0003-4819-111-1-28. [DOI] [PubMed] [Google Scholar]
  27. Rump J. A., Schölmerich J., Gross V., Roth M., Helfesrieder R., Rautmann A., Lüdemann J., Gross W. L., Peter H. H. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology. 1990 Nov;181(4-5):406–413. doi: 10.1016/S0171-2985(11)80509-7. [DOI] [PubMed] [Google Scholar]
  28. Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990 Aug;86(2):202–210. doi: 10.1016/s0091-6749(05)80067-3. [DOI] [PubMed] [Google Scholar]
  29. Snook J. A., Chapman R. W., Fleming K., Jewell D. P. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1989 Apr;76(1):30–33. [PMC free article] [PubMed] [Google Scholar]
  30. Soukiasian S. H., Foster C. S., Niles J. L., Raizman M. B. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology. 1992 Jan;99(1):125–132. doi: 10.1016/s0161-6420(92)32027-5. [DOI] [PubMed] [Google Scholar]
  31. Tervaert J. W., Huitema M. G., Hené R. J., Sluiter W. J., The T. H., van der Hem G. K., Kallenberg C. G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  32. Tervaert J. W., van der Woude F. J., Fauci A. S., Ambrus J. L., Velosa J., Keane W. F., Meijer S., van der Giessen M., van der Hem G. K., The T. H. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989 Nov;149(11):2461–2465. doi: 10.1001/archinte.149.11.2461. [DOI] [PubMed] [Google Scholar]
  33. Velosa J. A., Homburger H. A., Holley K. E. Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitis. Mayo Clin Proc. 1993 Jun;68(6):561–565. doi: 10.1016/s0025-6196(12)60370-x. [DOI] [PubMed] [Google Scholar]
  34. Whittingham S., Morstyn G., Wilson J. W., Vadas M. A. An autoantibody reactive with nuclei of polymorphonuclear neutrophils: a cell differentiation marker. Blood. 1981 Oct;58(4):768–771. [PubMed] [Google Scholar]
  35. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12–13. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES